Harish Shantharam
Nessuna posizione attualmente
Profilo
Harish Shantharam is currently the Chief Financial Officer at UCLA Anderson School of Management.
Previously, he served as the Chief Financial & Accounting Officer at CymaBay Therapeutics, Inc. from 2023 to 2024.
Prior to that, he was the Vice President-Global Commercial Finance at Gilead Sciences, Inc. from 2011 to 2022.
He also held the position of Head-Business Development at Amgen, Inc. from 2004 to 2011.
Mr. Shantharam holds a graduate degree from The University of Texas at Arlington and an MBA from UCLA Anderson School of Management.
Precedenti posizioni note di Harish Shantharam
| Società | Posizione | Fine |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Director of Finance/CFO | 22/03/2024 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/05/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/11/2011 |
Formazione di Harish Shantharam
| The University of Texas at Arlington | Graduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
- Borsa valori
- Insiders
- Harish Shantharam
